AstraZeneca Acquires Amolyt Pharma for $1.05B, Expanding Rare-Disease Portfolio
Drugmaker AstraZeneca said on Thursday it would acquire rare endocrine diseases-focused firm Amolyt Pharma for $1.05 billion in cash, in…
Drugmaker AstraZeneca said on Thursday it would acquire rare endocrine diseases-focused firm Amolyt Pharma for $1.05 billion in cash, in…
German sportswear giant Adidas posted its first annual loss in more than 30 years on Wednesday and warned sales in…
Oracle Corp. surged 13% after reporting a spike in bookings attributed to its closely watched cloud computing business, showing progress…
US Dollar vs Japanese Yen Technical Analysis As you can see, we pulled back just a bit during the trading…
Apple AAPL -2.84% stock fell again in Tuesday trading, leaving investors to wonder when the iPhone maker’s shares will bottom…
Cellnex on Tuesday said it expects revenues of up to 4.7 billion euros ($5.1 billion) and adjusted core earnings of…
South Korean car maker Kia Corp is in talks with Thailand to build an electric vehicle facility in the Southeast…
Oil steadied near the highest level this year after OPEC+ extended its production cuts to the end of next quarter.…
Shares of Salesforce (CRM) are moving up as the company reported fourth-quarter earnings, posting adjusted earnings per share of $2.29…
HP Inc. CEO Enrique Lores says the stage is set for a recovery in PC demand later this year, even…